Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Krebs Biochemicals & Industries is an Indian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates using chemical synthesis and fermentation technologies. Founded in 1991, the company operates manufacturing facilities in Nellore and Vizag, India, which are equipped for large-scale fermentation and chemical processes. Krebs is a subsidiary of Ipca Laboratories, which holds a significant stake in the company. Their product portfolio includes various APIs such as statins and other specialty chemicals, serving both domestic and international markets. The company focuses on cost-effective production through process optimization and vertical integration within the Ipca group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Krebs Biochemicals & Industries.